Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases

D. Negi, S. Granak, S. Shorter, VB. O'Leary, I. Rektor, SV. Ovsepian

. 2023 ; 20 (3) : 767-778. [pub] 20230308

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010538

In neurodegenerative diseases, changes in neuronal proteins in the cerebrospinal fluid and blood are viewed as potential biomarkers of the primary pathology in the central nervous system (CNS). Recent reports suggest, however, that level of neuronal proteins in fluids also alters in several types of epilepsy in various age groups, including children. With increasing evidence supporting clinical and sub-clinical seizures in Alzheimer's disease, Lewy body dementia, Parkinson's disease, and in other less common neurodegenerative conditions, these findings call into question the specificity of neuronal protein response to neurodegenerative process and urge analysis of the effects of concomitant epilepsy and other comorbidities. In this article, we revisit the evidence for alterations in neuronal proteins in the blood and cerebrospinal fluid associated with epilepsy with and without neurodegenerative diseases. We discuss shared and distinctive characteristics of changes in neuronal markers, review their neurobiological mechanisms, and consider the emerging opportunities and challenges for their future research and diagnostic use.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010538
003      
CZ-PrNML
005      
20230801132503.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13311-023-01355-7 $2 doi
035    __
$a (PubMed)36884195
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Negi, Deepika $u Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime, Kent, ME4 4TB, UK
245    10
$a Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases / $c D. Negi, S. Granak, S. Shorter, VB. O'Leary, I. Rektor, SV. Ovsepian
520    9_
$a In neurodegenerative diseases, changes in neuronal proteins in the cerebrospinal fluid and blood are viewed as potential biomarkers of the primary pathology in the central nervous system (CNS). Recent reports suggest, however, that level of neuronal proteins in fluids also alters in several types of epilepsy in various age groups, including children. With increasing evidence supporting clinical and sub-clinical seizures in Alzheimer's disease, Lewy body dementia, Parkinson's disease, and in other less common neurodegenerative conditions, these findings call into question the specificity of neuronal protein response to neurodegenerative process and urge analysis of the effects of concomitant epilepsy and other comorbidities. In this article, we revisit the evidence for alterations in neuronal proteins in the blood and cerebrospinal fluid associated with epilepsy with and without neurodegenerative diseases. We discuss shared and distinctive characteristics of changes in neuronal markers, review their neurobiological mechanisms, and consider the emerging opportunities and challenges for their future research and diagnostic use.
650    _2
$a dítě $7 D002648
650    _2
$a lidé $7 D006801
650    12
$a neurodegenerativní nemoci $x komplikace $x diagnóza $7 D019636
650    _2
$a proteiny tau $7 D016875
650    12
$a Alzheimerova nemoc $x patologie $7 D000544
650    _2
$a amyloidní beta-protein $7 D016229
650    12
$a epilepsie $7 D004827
650    _2
$a biologické markery $7 D015415
655    _2
$a časopisecké články $7 D016428
700    1_
$a Granak, Simon $u National Institute of Mental Health, Topolova 748, Klecany, 25067, Czech Republic
700    1_
$a Shorter, Susan $u Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime, Kent, ME4 4TB, UK
700    1_
$a O'Leary, Valerie B $u Department of Medical Genetics, Third Faculty of Medicine, Charles University, Ruská 87, Prague, 10000, Czech Republic
700    1_
$a Rektor, Ivan $u First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Multimodal and Functional Neuroimaging Research Group, CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Ovsepian, Saak V $u Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime, Kent, ME4 4TB, UK. s.v.ovsepian@gre.ac.uk $1 https://orcid.org/0000000295224159
773    0_
$w MED00167290 $t Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics $x 1878-7479 $g Roč. 20, č. 3 (2023), s. 767-778
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36884195 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132459 $b ABA008
999    __
$a ok $b bmc $g 1963141 $s 1196803
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 20 $c 3 $d 767-778 $e 20230308 $i 1878-7479 $m Neurotherapeutics $n Neurotherapeutics $x MED00167290
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Možnosti archivace